Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, lab study reveals
Date: August 6, 2021
Source: University of Birmingham
Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, lab study reveals -- ScienceDaily
Summary:
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, a new study in the laboratory reveals. ....